Introduction.
Little is known about the role of hormones in the growth and differentiation of fetal tissues. Though fetal plasma contains large quantities of growth hormone, fetal growth is not appreciably perturbed by a deficiency of intrauterine growth hormone (Nanagas, 1925 ; Blizzard and Alberts, 1956 ; Rimoin, Merimee and McKusick, 1966) . Similarly, normal growth has been observed in rat, rabbit, sheep and monkey fetuses after in utero decapitation or hypophysectomy (Jost, 1966 ; Liggins and Kennedy,1968 ; Chez et al., 1970) .
It is now believed that growth hormone does not act directly on skeletal growth but through the mediation of small peptidic growth factors, the somatomedins. Somatomedin-A (Sm-A) bioactivity has been defined as the factor stimulating S0 4 uptake into chick embryo pelvis in vitro (Uthne, 1973) . Somatomedins are found not only in blood, but in other body fluids such as the cerebrospinal fluid (Beaton, Sagel and Distiller, 1975) or amniotic fluid (Andersen, Kastrup and Lebech, 1974 ; Wright and Bala, 1975 ; Bala and Smith, 1976) . Some authors studying humans have reported a significant correlation between birth size and Sm-P (Gluckman and Brinsmead, 1976) , Sm-C (Underwood et al., 1978) or NSILA (Heinrich et al., 1978) in cord blood.
We wondered if these correlations could be found in animals. The Amniotic fluids had a generally low activity. 35 SO i uptake was below 0.2 U/ml in 90 p. 100 of the samples and 3 H-thymidine uptake was also below that value in 50 p. 100 of the samples. (table 3) . However, further studies at earlier gestational stages are needed to confirm these hypotheses.
The lack of correlation between 35 S0 4 and 3 H-thymidine incorporations for a same sample, the discrepancy between them (one sample may both inhibit 35 S0 4 and stimulate 3 H-thymidine uptake), the dissociation of Sm activities (as judged by S0 4 or by 3 H-thymidine, fig. 3) 
